Citadel Advisors
NUVL

Citadel Advisors’s Nuvalent NUVL Stock Holding History

Citadel Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
28,300
+18,000
+175% +$1.94M ﹤0.01% 5383
2026
Q1 		$1.06M Sell
10,300
-1,000
-9% -$102K ﹤0.01% 7537
2025
Q4 		$1.14M Buy
11,300
+6,100
+117% +$601K ﹤0.01% 7109
2025
Q3 		$450K Sell
5,200
-14,200
-73% -$1.12M ﹤0.01% 9398
2025
Q2 		$1.48M Sell
19,400
-3,600
-16% -$263K ﹤0.01% 6289
2025
Q1 		$1.63M Sell
23,000
-19,700
-46% -$1.54M ﹤0.01% 5925
2024
Q4 		$3.34M Buy
42,700
+31,700
+288% +$2.96M ﹤0.01% 4656
2024
Q3 		$1.13M Sell
11,000
-50,700
-82% -$4.21M ﹤0.01% 6644
2024
Q2 		$4.68M Sell
61,700
-11,100
-15% -$790K ﹤0.01% 3848
2024
Q1 		$5.47M Buy
72,800
+47,500
+188% +$3.78M ﹤0.01% 3812
2023
Q4 		$1.86M Buy
25,300
+9,800
+63% +$606K ﹤0.01% 5488
2023
Q3 		$713K Buy
15,500
+15,200
+5,067% +$675K ﹤0.01% 7302
2023
Q2 		$12.7K Sell
300
-10,100
-97% -$382K ﹤0.01% 13067
2023
Q1 		$271K Hold
10,400
– – ﹤0.01% 9578
2022
Q4 		$310K Buy
+10,400
New +$290K ﹤0.01% 9246

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Citadel Advisors's NUVL Position: Q2 2026 in Review

Citadel Advisors reduced its Nuvalent (NUVL) stake by 74% in Q2 2026, selling an estimated $13.2M and leaving 43,937 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4579.

Citadel Advisors first reported a position in NUVL in Q1 2022 and has held it in 18 quarters since. The position peaked at $24.8M in Q3 2024. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Citadel Advisors held 43,937 shares of Nuvalent worth $5.43M as of Q2 2026.
  • Citadel Advisors sold 122,836 Nuvalent shares in Q2 2026, an estimated $13.2M.
  • Nuvalent made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4579 holding.
  • Citadel Advisors first reported a position in Nuvalent in Q1 2022 and has held it in 18 quarters since.
  • Citadel Advisors's Nuvalent position peaked at $24.8M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.